title: Treatment of gingival hyperplasia secondary to cyclosporine by the new macrolide azithromycin.
authors.affiliation: Nephrology Department, Hospital del Mar, Barcelona, Spain.
authors.forename: J M
authors.initials: JM
authors.lastname: Puig
authors.forename: J
authors.initials: J
authors.lastname: Lloveras
authors.forename: J M
authors.initials: JM
authors.lastname: Bosch
authors.forename: A
authors.initials: A
authors.lastname: Munné
authors.forename: M
authors.initials: M
authors.lastname: Mir
authors.forename: F
authors.initials: F
authors.lastname: Barbosa
authors.forename: J
authors.initials: J
authors.lastname: Masramon
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D017963:Azithromycin / Q000008:administration & dosage*; D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D005885:Gingival Hyperplasia / Q000139:chemically induced* / Q000188:drug therapy*; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D016030:Kidney Transplantation
chemical_list: D000900:Anti-Bacterial Agents; D017963:Azithromycin; D016572:Cyclosporine